Skip to main content
Premium Trial:

Request an Annual Quote

Genmab Extends License for IDBS' ActivityBase Screening Software

NEW YORK (GenomeWeb News) — Dutch company Genmab has extended its agreement to use ID Business Solutions’ ActivityBase Xtended Edition screening software, Guildford, UK-based IDBS said today.
 
Under the agreement, Genmab’s Hybridoma Discovery department will use the software to mange the design, capture, storage, and retrieval of plate-based screening data, IDBS said.
 
IDBS said Genmab initially licensed the software in 2006 to manage data from functional screening of human monoclonal antibody therapies, and now has “more than doubled” that number of ActivityBase XE licenses.
 
IDBS’ founder and CEO Neil Kipling said the software supports high-throughput and high-content screening and “new screening methodologies.”
 
Financial terms of the agreement were not released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.